David William Fenton
University of Alberta · 50 works · 4,843 citations · h-index 19
Top works
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21
- Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study
- A case controlled study of the outcome of pregnancy following loop diathermy excision of the transformation zone
- Gastric Acid Suppression Is Associated With Decreased Erlotinib Efficacy in Non–Small-Cell Lung Cancer
- Quantitative microcolpohysteroscopic assessment of the extent of endocervical involvement by cervical intraepithelial neoplasia
- Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer
- Outcome analysis of breast cancer patients who declined evidence-based treatment
- Acute Fatty Liver of Pregnancy 1
- OCCULT CERVICAL CARCINOMA REVEALED BY LARGE LOOP DIATHERMY
- Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29
- Feasibility and preliminary efficacy of progressive resistance exercise training in lung cancer survivors
- Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24
- A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer
- Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab
- Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practice
- Timeliness of cancer care from diagnosis to treatment: a comparison between patients with breast, colon, rectal or lung cancer
- Ultrasonic tissue characterization of the placenta: Is it of clinical value?
- A pilot study of the benefit of colposcopy as a further screening procedure within the community health service
- The Lack of Long-Term Effect of Cisplatin Based Combination Chemotherapy on Serum Cholesterol for Treatment of Testicular Cancer